Vitrafy Life Sciences Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Vitrafy Life Sciences stock has a consensus rating of "Strong Buy" and an average price target of $2.77. The average 1-year stock price forecast is 16.06% lower than the current stock price, while the lowest is $2.47 (-25.15%) and the highest is $3.08 (-6.67%).

Price Target: $2.77 (-16.06%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$2.47	$2.77	$2.77	$3.08
Change	-25.15%	-16.06%	-16.06%	-6.67%

* Price targets were last updated on Apr 29, 2026.

Analyst Ratings

The average analyst rating for Vitrafy Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Martyn Jacobs Bell Potter	Bell Potter	Buy Maintains $2.25 → $3.00	Buy	Maintains	$2.25 → $3.00	-9.09%	Apr 29, 2026
Tom Godfrey Ord Minnett	Ord Minnett	Buy Maintains $2.50 → $2.40	Buy	Maintains	$2.50 → $2.40	-27.27%	Mar 24, 2026

Financial Forecast

Revenue This Year

1.99M

from 1.05M

89.95%

from 1.05M

Revenue Next Year

7.36M

from 1.99M

270.05%

from 1.99M

EPS This Year

-0.27

from -0.73

EPS Next Year

-0.26

from -0.27

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026
Revenue	1.83M	2.06M	2.06M	1.05M	1.99M
Revenue Growth	-	12.63%	0.17%	-49.14%	89.95%
Gross Profit	1.82M	2.03M	2.06M	1.05M	521.44K
Gross Margin	99.68%	98.62%	100.00%	100.00%	26.20%
Operating Income	-4.61M	-7.14M	-8.67M	-15.57M	-19.34M
Net Income	-7.66M	-7.81M	-10.43M	-32.71M	-18.64M
EPS	-	-	-	-0.73	-0.27
Free Cash Flow	-	734.91K	-9.10M	-29.04M	-17.56M
No. Analysts	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue	2026	2027	2028
High	3.8M
Avg	2.0M
Low	216,497

Revenue Growth

Revenue Growth	2026	2027	2028
High	259.2%
Avg	90.0%
Low	-79.3%

EPS Forecast

EPS	2026	2027	2028
High	-0.24
Avg	-0.27
Low	-0.29

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-